OutSee Limited

25 Nov, 2024
Briony Quested
On a mission to uncover the untapped value in our genome, the genomics analysis expert OutSee Limited uses AI-powered predictive genomics for novel drug target discovery and validation.
Thumbnail
OutSee founder and CEO, Dr Julian Gough. Credit – MRC Laboratory of Molecular Biology (LMB).

The highly respected academic scientist Dr Julian Gough founded the company to exploit large-scale genomics datasets and invent and develop world-leading bioinformatics tools and resources for academia.

Harnessing genomics, AI and cohort analysis techniques, its proprietary AI technology Nomaly allows scientists to analyse genetic cohorts to discover novel causal mechanisms. Its system produces results not currently available from other methods.

The company is set to announce a significant fundraise and is currently hiring.

Career opportunities at OutSee Limited